Becton, Dickinson and Company BDX, popularly known as BD, recently introduced a new robotic track system for the BD Kiestra microbiology laboratory solution — the BD Kiestra 3rd Generation Total Lab ...
FRANKLIN LAKES, N.J., Dec. 15, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the expansion of its respiratory and ...
Becton, Dickinson and Company BDX, popularly known as BD, recently announced the expansion of its respiratory and sexually transmitted infection (STI) diagnostics portfolio in Europe. This follows the ...
Focus is on tests for Europe to detect infections in transplant patients. BD Diagnostics and Biodiversity will work together on a molecular diagnostic menu for immunocompromised patients based on on ...
Belgian firm will head development of assay panels for respiratory and gastrointestinal pathogens, and for meningitis diagnosis. BD Diagnostics is collaborating with Belgian IVD specialist Diagenode ...
BD (Becton, Dickinson and Company), a leading global medical technology company, along with Check-Points Health B.V., announced today that FDA 510(k) clearance was obtained for a molecular screening ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback